To assess the correlation between GPX2 expression and prognosis, immunohistochemical staining was conducted on tissue microarray from 160 GC patients (Supplementary Table 2), and survival analysis revealed a poorer prognosis in patients with high GPX2 expression (Fig. 2E–G). This evidence concerns the gene GPX2 and gastric cancer.